APO RESEARCH · REPORT
Swine Vaccines
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Product & engineering
Understand the product.
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
Selected research
Industry Research
Swine Vaccines Industry Research Report 2026
Market perspective
The immune system responds by producing antibodies that destroy the infectious agents, usually in co-operation with specialised body cells or by neutralising the toxins that are responsible for the disease. This process of stimulating immunity is called vaccination.
Vaccines contain antigens from viruses, bacteria, bacterial toxins, or parasites. They are given to pigs, usually by injection, to stimulate an immune response which will protect the pigs against later natural infection with the organism from which the vaccine was derived. Most stimulate both a humoral response and a cell-mediated response.
Vaccines can either contain viable organisms that will multiply in the pig, or inactivated ones that will not multiply in the pig.
Read the full market overview
China is the largest region of Swine Vaccines, with a share more than 40%, followed by Europe and North America, etc. Merck, Boehringer Ingelheim, Jinyu Bio-Technology, CAHIC and Tecon are the top 5 manufacturers of industry, and they had a more than 55% combined market share.
Report Scope
This report quantifies the global Swine Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (M Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Doses) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Swine Vaccines Market by Company
Merck
Boehringer Ingelheim
Jinyu Bio-Technology
CAHIC
Tecon
Zoetis
Ceva
Hile Bio
Chopper Biology
WINSUN
Hipra
Ringpu Biology
ChengDu Tecbond
DHN
CAVAC
Virbac
HVRI
Bioveta
Swine Vaccines Segment by Type
CSF Vaccines
FMD Vaccines
Porcine Circovirus Vaccines
PRRS Vaccines
Others
Swine Vaccines Segment by Application
Government Tender
Market Sales
Swine Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Swine Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Swine Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Swine Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- CSF Vaccines
- FMD Vaccines
- Porcine Circovirus Vaccines
- PRRS Vaccines
- Others
Applications
- Government Tender
- Market Sales
Companies covered
- Merck
- Boehringer Ingelheim
- Jinyu Bio-Technology
- CAHIC
- Tecon
- Zoetis
- Ceva
- Hile Bio
- Chopper Biology
- WINSUN
- Hipra
- Ringpu Biology
- ChengDu Tecbond
- DHN
- CAVAC
- Virbac
- HVRI
- Bioveta
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Swine Vaccines Market Size (2021-2032)
- 2.2.2 Global Swine Vaccines Sales (2021-2032)
- 2.2.3 Global Swine Vaccines Market Average Price (2021-2032)
- 2.3 Swine Vaccines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 CSF Vaccines
- 2.3.3 FMD Vaccines
- 2.3.4 Porcine Circovirus Vaccines
- 2.3.5 PRRS Vaccines
- 2.3.6 Others
- 2.4 Swine Vaccines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Government Tender
- 2.4.3 Market Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Swine Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Swine Vaccines Sales (M Doses) of Manufacturers (2021-2026)
- 3.3 Global Swine Vaccines Revenue of Manufacturers (2021-2026)
- 3.4 Global Swine Vaccines Average Price by Manufacturers (2021-2026)
- 3.5 Global Swine Vaccines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Swine Vaccines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Swine Vaccines, Product Type & Application
- 3.8 Global Manufacturers of Swine Vaccines, Established Date
- 3.9 Global Swine Vaccines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Merck
- 4.1.1 Merck Company Information
- 4.1.2 Merck Business Overview
- 4.1.3 Merck Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Merck Swine Vaccines Product Portfolio
- 4.1.5 Merck Recent Developments
- 4.2 Boehringer Ingelheim
- 4.2.1 Boehringer Ingelheim Company Information
- 4.2.2 Boehringer Ingelheim Business Overview
- 4.2.3 Boehringer Ingelheim Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boehringer Ingelheim Swine Vaccines Product Portfolio
- 4.2.5 Boehringer Ingelheim Recent Developments
- 4.3 Jinyu Bio-Technology
- 4.3.1 Jinyu Bio-Technology Company Information
- 4.3.2 Jinyu Bio-Technology Business Overview
- 4.3.3 Jinyu Bio-Technology Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jinyu Bio-Technology Swine Vaccines Product Portfolio
- 4.3.5 Jinyu Bio-Technology Recent Developments
- 4.4 CAHIC
- 4.4.1 CAHIC Company Information
- 4.4.2 CAHIC Business Overview
- 4.4.3 CAHIC Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 CAHIC Swine Vaccines Product Portfolio
- 4.4.5 CAHIC Recent Developments
- 4.5 Tecon
- 4.5.1 Tecon Company Information
- 4.5.2 Tecon Business Overview
- 4.5.3 Tecon Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Tecon Swine Vaccines Product Portfolio
- 4.5.5 Tecon Recent Developments
- 4.6 Zoetis
- 4.6.1 Zoetis Company Information
- 4.6.2 Zoetis Business Overview
- 4.6.3 Zoetis Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zoetis Swine Vaccines Product Portfolio
- 4.6.5 Zoetis Recent Developments
- 4.7 Ceva
- 4.7.1 Ceva Company Information
- 4.7.2 Ceva Business Overview
- 4.7.3 Ceva Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Ceva Swine Vaccines Product Portfolio
- 4.7.5 Ceva Recent Developments
- 4.8 Hile Bio
- 4.8.1 Hile Bio Company Information
- 4.8.2 Hile Bio Business Overview
- 4.8.3 Hile Bio Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hile Bio Swine Vaccines Product Portfolio
- 4.8.5 Hile Bio Recent Developments
- 4.9 Chopper Biology
- 4.9.1 Chopper Biology Company Information
- 4.9.2 Chopper Biology Business Overview
- 4.9.3 Chopper Biology Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Chopper Biology Swine Vaccines Product Portfolio
- 4.9.5 Chopper Biology Recent Developments
- 4.10 WINSUN
- 4.10.1 WINSUN Company Information
- 4.10.2 WINSUN Business Overview
- 4.10.3 WINSUN Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 WINSUN Swine Vaccines Product Portfolio
- 4.10.5 WINSUN Recent Developments
- 4.11 Hipra
- 4.11.1 Hipra Company Information
- 4.11.2 Hipra Business Overview
- 4.11.3 Hipra Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hipra Swine Vaccines Product Portfolio
- 4.11.5 Hipra Recent Developments
- 4.12 Ringpu Biology
- 4.12.1 Ringpu Biology Company Information
- 4.12.2 Ringpu Biology Business Overview
- 4.12.3 Ringpu Biology Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ringpu Biology Swine Vaccines Product Portfolio
- 4.12.5 Ringpu Biology Recent Developments
- 4.13 ChengDu Tecbond
- 4.13.1 ChengDu Tecbond Company Information
- 4.13.2 ChengDu Tecbond Business Overview
- 4.13.3 ChengDu Tecbond Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 ChengDu Tecbond Swine Vaccines Product Portfolio
- 4.13.5 ChengDu Tecbond Recent Developments
- 4.14 DHN
- 4.14.1 DHN Company Information
- 4.14.2 DHN Business Overview
- 4.14.3 DHN Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 DHN Swine Vaccines Product Portfolio
- 4.14.5 DHN Recent Developments
- 4.15 CAVAC
- 4.15.1 CAVAC Company Information
- 4.15.2 CAVAC Business Overview
- 4.15.3 CAVAC Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 CAVAC Swine Vaccines Product Portfolio
- 4.15.5 CAVAC Recent Developments
- 4.16 Virbac
- 4.16.1 Virbac Company Information
- 4.16.2 Virbac Business Overview
- 4.16.3 Virbac Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Virbac Swine Vaccines Product Portfolio
- 4.16.5 Virbac Recent Developments
- 4.17 HVRI
- 4.17.1 HVRI Company Information
- 4.17.2 HVRI Business Overview
- 4.17.3 HVRI Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 HVRI Swine Vaccines Product Portfolio
- 4.17.5 HVRI Recent Developments
- 4.18 Bioveta
- 4.18.1 Bioveta Company Information
- 4.18.2 Bioveta Business Overview
- 4.18.3 Bioveta Swine Vaccines Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Bioveta Swine Vaccines Product Portfolio
- 4.18.5 Bioveta Recent Developments
5 Global Swine Vaccines Market Scenario by Region
- 5.1 Global Swine Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Swine Vaccines Sales by Region: 2021-2032
- 5.2.1 Global Swine Vaccines Sales by Region: 2021-2026
- 5.2.2 Global Swine Vaccines Sales by Region: 2027-2032
- 5.3 Global Swine Vaccines Revenue by Region: 2021-2032
- 5.3.1 Global Swine Vaccines Revenue by Region: 2021-2026
- 5.3.2 Global Swine Vaccines Revenue by Region: 2027-2032
- 5.4 North America Swine Vaccines Market Facts & Figures by Country
- 5.4.1 North America Swine Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Swine Vaccines Sales by Country (2021-2032)
- 5.4.3 North America Swine Vaccines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Swine Vaccines Market Facts & Figures by Country
- 5.5.1 Europe Swine Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Swine Vaccines Sales by Country (2021-2032)
- 5.5.3 Europe Swine Vaccines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Swine Vaccines Market Facts & Figures by Country
- 5.6.1 Asia Pacific Swine Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Swine Vaccines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Swine Vaccines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Swine Vaccines Market Facts & Figures by Country
- 5.7.1 South America Swine Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Swine Vaccines Sales by Country (2021-2032)
- 5.7.3 South America Swine Vaccines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Swine Vaccines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Swine Vaccines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Swine Vaccines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Swine Vaccines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Swine Vaccines Sales by Type (2021-2032)
- 6.1.1 Global Swine Vaccines Sales by Type (2021-2032) & (M Doses)
- 6.1.2 Global Swine Vaccines Sales Market Share by Type (2021-2032)
- 6.2 Global Swine Vaccines Revenue by Type (2021-2032)
- 6.2.1 Global Swine Vaccines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Swine Vaccines Revenue Market Share by Type (2021-2032)
- 6.3 Global Swine Vaccines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Swine Vaccines Sales by Application (2021-2032)
- 7.1.1 Global Swine Vaccines Sales by Application (2021-2032) & (M Doses)
- 7.1.2 Global Swine Vaccines Sales Market Share by Application (2021-2032)
- 7.2 Global Swine Vaccines Revenue by Application (2021-2032)
- 7.2.1 Global Swine Vaccines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Swine Vaccines Revenue Market Share by Application (2021-2032)
- 7.3 Global Swine Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Swine Vaccines Value Chain Analysis
- 8.1.1 Swine Vaccines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Swine Vaccines Production Mode & Process
- 8.2 Swine Vaccines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Swine Vaccines Distributors
- 8.2.3 Swine Vaccines Customers
9 Global Swine Vaccines Analyzing Market Dynamics
- 9.1 Swine Vaccines Industry Trends
- 9.2 Swine Vaccines Industry Drivers
- 9.3 Swine Vaccines Industry Opportunities and Challenges
- 9.4 Swine Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst